CELMoDs Tomorrow

A panel of experts explore the potential of next-generation #myeloma treatments, focusing on Cereblon E3 ligase modulators (CELMoDs) and the critical need for equitable patient access.

The panel includes:

• Dana Dornsife – Founder, Lazarex Cancer Foundation
• Jenny Ahlstrom – Founder and Chief Executive Officer, Healthtree Foundation
• Diane Moran – Business Relationship Management, International Myeloma Foundation
• Aïcha Diallo, MPH, CHES – Vice President of Programs, Patient Empowerment Network
• Christopher Peña – Director, Educational Programs, Multiple Myeloma Research Foundation
• Pamela Price – Deputy Director, Balm in Gilead

---

Brought to you by the Multiple Myeloma Collective, Sponsored by Bristol Myers Squibb